Meagan Thistle

News
First Batches of Novel Oral Drug Targeting Suicidal Bipolar Depression Released
11/15/2022
First batches of D-cycloserine and lurasidone (NRX-101), a phase 3-ready investigational drug targeting suicidal bipolar depression, released.
First batches of D-cycloserine and lurasidone (NRX-101), a phase 3-ready investigational drug targeting suicidal bipolar depression, released.
First batches of D-cycloserine...
11/15/2022
Psych Congress Network
Julie Carbray greets an attendee at the 2023 NP Institute in Boston
Conference Coverage
Second Annual Psych Congress NP Institute Promises Robust Content and Networking Opportunities for APPs
03/15/2024
The 2024 Psych Congress NP Institute in its second year promises to "take a deep dive into everything you need to know about psychopharmacology but have been afraid to ask."
The 2024 Psych Congress NP Institute in its second year promises to "take a deep dive into everything you need to know about psychopharmacology but have been afraid to ask."
The 2024 Psych Congress NP...
03/15/2024
Psych Congress Network
News
Psych Congress Europe to Take Place in Barcelona, Spain
12/23/2021
Psych Congress Europe will be held in Barcelona, Spain, February 23-25 and promises to connect the global mental healthcare community with updated approaches in practical psychopharmacology.
Psych Congress Europe will be held in Barcelona, Spain, February 23-25 and promises to connect the global mental healthcare community with updated approaches in practical psychopharmacology.
Psych Congress Europe will be...
12/23/2021
Psych Congress Network
News
ECT Shows Small Advantage Over Ketamine in Major Depressive Episode Treatment
04/14/2023
Electroconvulsive therapy (ECT) may be superior to ketamine in treating major depressive episode (MDE) in adults, according to a study published in JAMA Psychiatry. 
Electroconvulsive therapy (ECT) may be superior to ketamine in treating major depressive episode (MDE) in adults, according to a study published in JAMA Psychiatry. 
Electroconvulsive therapy (ECT)...
04/14/2023
Psych Congress Network
News
Hormonal Contraception-Associated Depressive Episodes May Be Linked to PPD Risk
07/14/2023
Depression associated with hormonal contraception (HC) use may indicate susceptibility to postpartum depression (PPD), linking depressive episodes with hormonal contributions, findings published in JAMA Psychiatry suggest.
Depression associated with hormonal contraception (HC) use may indicate susceptibility to postpartum depression (PPD), linking depressive episodes with hormonal contributions, findings published in JAMA Psychiatry suggest.
Depression associated with...
07/14/2023
Psych Congress Network
News
FDA Subcommittee Votes Against Pimavanserin for Alzheimer Disease Psychosis Therapy
06/28/2022
FDA Psychopharmacologic Drugs Advisory Committee (PDAC) voted 9 to 3 that there is not sufficient evidence pimavanserin is effective in the treatment of hallucinations and delusions associated with Alzheimer disease psychosis.
FDA Psychopharmacologic Drugs Advisory Committee (PDAC) voted 9 to 3 that there is not sufficient evidence pimavanserin is effective in the treatment of hallucinations and delusions associated with Alzheimer disease psychosis.
FDA Psychopharmacologic Drugs...
06/28/2022
Psych Congress Network
NEI Congress
News
NEI Congress Kicks Off in Colorado Springs and Online With a Focus on Pediatric Psychiatry
11/08/2023
The 19th Annual NEI Congress off to an exciting start in Colorado Springs, CO.
The 19th Annual NEI Congress off to an exciting start in Colorado Springs, CO.
The 19th Annual NEI Congress off...
11/08/2023
Psychiatry & Behavioral Health
fda
News
FDA Approves Iloperidone for Acute Treatment of Bipolar I Disorder
04/08/2024
Ilperidone, already approved for acute schizophrenia treatment, received FDA approval on Friday for acute treatment of manic or mixed episodes associated with bipolar I in adults.
Ilperidone, already approved for acute schizophrenia treatment, received FDA approval on Friday for acute treatment of manic or mixed episodes associated with bipolar I in adults.
Ilperidone, already approved for...
04/08/2024
Psych Congress Network
pop quiz
Quiz
What is the heritability of ADHD, according to the DSM-5-TR?
12/06/2022
According to the DSM-5-TR, the heritability of ADHD is approximately what percent? Take the quiz to find out!
According to the DSM-5-TR, the heritability of ADHD is approximately what percent? Take the quiz to find out!
According to the DSM-5-TR, the...
12/06/2022
Psych Congress Network
brain imaging
News
Overlooked Concussion in Children May Cause Mental Health Comorbidities
05/02/2024
Children who show significant symptoms after head injury are more likely to experience mental and social disturbances and require mental health services, but 23% aren't being evaluated for concussion or brain trauma.
Children who show significant symptoms after head injury are more likely to experience mental and social disturbances and require mental health services, but 23% aren't being evaluated for concussion or brain trauma.
Children who show significant...
05/02/2024
Psych Congress Network

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use